These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9626630)
1. A third-generation bisphosphonate, YM175, inhibits osteoclast formation in murine cocultures by inhibiting proliferation of precursor cells via supporting cell-dependent mechanisms. Nishikawa M; Yamamoto M; Murakami T; Akatsu T; Kugai N; Nagata N J Bone Miner Res; 1998 Jun; 13(6):986-95. PubMed ID: 9626630 [TBL] [Abstract][Full Text] [Related]
2. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Nagai M; Sato N Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Nishikawa M; Akatsu T; Katayama Y; Yasutomo Y; Kado S; Kugal N; Yamamoto M; Nagata N Bone; 1996 Jan; 18(1):9-14. PubMed ID: 8717530 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Murakami T; Yamamoto M; Ono K; Nishikawa M; Nagata N; Motoyoshi K; Akatsu T Biochem Biophys Res Commun; 1998 Nov; 252(3):747-52. PubMed ID: 9837778 [TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. Nakagawa N; Yasuda H; Yano K; Mochizuki Si; Kobayashi N; Fujimoto H; Yamaguchi K; Shima N; Morinaga T; Higashio K Biochem Biophys Res Commun; 1999 Nov; 265(1):45-50. PubMed ID: 10548488 [TBL] [Abstract][Full Text] [Related]
7. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms. O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639 [TBL] [Abstract][Full Text] [Related]
8. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
9. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells. Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173 [TBL] [Abstract][Full Text] [Related]
10. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Udagawa N; Takahashi N; Akatsu T; Sasaki T; Yamaguchi A; Kodama H; Martin TJ; Suda T Endocrinology; 1989 Oct; 125(4):1805-13. PubMed ID: 2676473 [TBL] [Abstract][Full Text] [Related]
11. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673 [TBL] [Abstract][Full Text] [Related]
12. Effects of interleukin-4 on the formation of macrophages and osteoclast-like cells. Riancho JA; Zarrabeitia MT; Mundy GR; Yoneda T; González-Macías J J Bone Miner Res; 1993 Nov; 8(11):1337-44. PubMed ID: 8266825 [TBL] [Abstract][Full Text] [Related]
13. High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells. Kanatani M; Sugimoto T; Kanzawa M; Yano S; Chihara K Biochem Biophys Res Commun; 1999 Jul; 261(1):144-8. PubMed ID: 10405337 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896 [TBL] [Abstract][Full Text] [Related]
15. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. van't Hof RJ; Ralston SH J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450 [TBL] [Abstract][Full Text] [Related]
17. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells. Kaji H; Sugimoto T; Kanatani M; Chihara K J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111 [TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722 [TBL] [Abstract][Full Text] [Related]
20. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2. Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]